Vesalius Therapeutics

Pioneering breakthrough treatments for common diseases

Cambridge, United States · Founded 2022 · $75.0M raised

Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$75.0M
Last Round
$75.0M Series CMar 2022
Rounds
1

About

Founded in 2020 and headquartered in Cambridge, Massachusetts, Vesalius Therapeutics discovers and develops drugs by targeting biological circuits within cells to treat diseases underlying common illnesses such as Parkinson's disease. The company is backed by Flagship Pioneering and has a strategic alliance with GSK to develop novel Parkinson's disease treatments.

Summary

Vesalius Therapeutics is a Healthcare company based in Cambridge, United States, founded in 2022. It has raised $75.0M in total across 1 round, most recently a $75.0M Series C round in Mar 2022. Investors include Flagship Pioneering, ARCH Venture Partners and Monograph Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CMar 2022
$75.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vesalius Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/vesalius-therapeutics"><img src="https://indexed.vc/api/badge/company/vesalius-therapeutics" alt="Vesalius Therapeutics on Indexed.vc" width="260" height="76" /></a>